A European Open-Label, Multicentre, Phase II Study of Inolimomab in the Treatment of Primary Steroid Resistant Acute Graft versus Host Disease (aGvHD) following allogeneic Stem Cell Transplantation for Hematological Malignancies in Adult patients
100 项与 O P I Products, Inc. 相关的临床结果
0 项与 O P I Products, Inc. 相关的专利(医药)
100 项与 O P I Products, Inc. 相关的药物交易
100 项与 O P I Products, Inc. 相关的转化医学